Compared with rival injectables Wegovy and Ozempic (semaglutide), Zepbound leads to greater weight loss. Learn about how it works, pricing, and side effects.

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for Medicare, which has long been barred from covering weight ...

Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi-dose KwikPen, giving patients a simpler way to receive a full month ...

If you are among the 40% of people in the U.S. with obesity, one of the most powerful actions you can take for your health is working with your healthcare provider to treat it. Obesity is nothing to ...

Ro said it will offer a "complete end-to-end" experience on a single platform and app, allowing eligible patients to receive a diagnosis and a prescription for Zepbound and have vials of the drug ...

Despite seeing some regain, patients in two trials maintained most of their weight loss after switching to either Foundayo or ...

The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device. Lilly says the new pen expands patient choice, ...

Used by millions of patients worldwide, the KwikPen® for single-patient use provides patients with a new option to receive Zepbound® Zepbound patients can access all doses in either multi-dose KwikPen ...

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

Taking GLP-1s once meant injecting a shot with a monthly price tag of $1,000. Today, patients interested in the wildly popular weight-loss drugs can choose among different types of injectables and ...